Early Real-World Data to Assess Benefits and Risks of COVID-19 Vaccines: A Systematic Review of Methods

Since the authorization of the first COVID-19 vaccines in December 2020, multiple studies using real-world data (RWD) have been published to assess their effectiveness/safety profile. This systematic review aimed to characterize the methods and outcomes of studies using RWD for assessment of COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Tatiane B., Roque, Fátima, Ida, Fidelia, Plácido, Ana I., Vu, Mai, Hernández-Muñoz, Jose J., Herdeiro, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697784/
https://www.ncbi.nlm.nih.gov/pubmed/36366404
http://dx.doi.org/10.3390/vaccines10111896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697784/
https://www.ncbi.nlm.nih.gov/pubmed/36366404
http://dx.doi.org/10.3390/vaccines10111896

Ejemplares similares